Mark Lubkeman — Chair
Managing Director and Senior Partner, The Boston Consulting Group
Former leader, Global Biopharma Sector and US Healthcare Practice
Former Trustee, California Science Center
Non-Executive Director Urban & Civic PLC, Foxtons Group PLC, and The Brunner Investment Trust PLC
Former Non-executive Director at Smith & Nephew PLC
Former London Senior Partner at KPMG
Head of US Cross Border Corporate Finance at Investec
Former Managing Director at East West Global Capital
Co-Founder and Board Director at Kindred
Former Chairman and Chief Executive Officer at Cowen Inc.
Founder and Former Chief Executive Officer at Ramius Capital Management
Former Chairman and Chief Executive Officer at Shearson Lehman Brothers
David Restrepo RPH
President at Vitahealth Apothecary
Chief Executive Officer at MUFG Securities EMEA PLC
Former Chief Executive Officer at Barclays Corporate Bank
Craig Vanderwagen, M.D, Chairman
Former Assistant Secretary for Preparedness and Response at U.S. Department of Health and Human Services
Retired Admiral from U.S. Public Health Service
Andrea Ballabio, Ph.D.
Professor at TIGEM (Italy) International
Expert on modulation of cell clearance for Neurodegenerative Disorders and Lysosomal Storage Disorders treatment
Stephen Cohen, LAc, MSOM
Founder AXIOM Holistic
Former Mergers and Acquisitions Transaction Advisor
Marc Patterson, M.D.
Professor of Neurology and Chair of the Division of Child and Adolescent Neurology at Mayo Clinic, Rochester, Minnesota
Research and practice focus on children with rare diseases including Niemann-Pick Disease type C (NPC) and GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease)
Bill Raub, Ph.D.
Former Acting Director of the National Institutes of Health
Former Scientific Advisor to HHS Secretary